증권 기록 · 과거 분기 (아카이브)
EVH
Evolent Health, Inc. · Healthcare · Medical - Healthcare Information Services
19추적 보유자
+1Δ 보유자
60.10M보유 주식 수
$508.46M보고 가치
+2신규 편입 포지션
−2청산
모멘텀 입력값 (비교 가능한 운용사):
보유자 폭 +5.6% ·
주식 흐름 +12.0% ·
순 신규 포지션 0.0%
— 산식
광범위한 매집 — 더 많은 보유자에 걸쳐 주식 수 증가
모든 소유권 수치: 추적 대상 13F 운용사 한정, 보통주 포지션, 보고 기간 Q3 2025
시계열 보유 현황
| 분기 | 보유자 | Δ | 주식 수 | 보고 가치 | 신규 | 청산 |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +6 | 70.64M | $382.54M | +11 | −4 |
| Q1 2026 | 73 | -12 | 65.20M | $148.81M | +7 | −20 |
| Q4 2025 | 86 | 0 | 77.77M | $307.90M | +1 | — |
| Q3 2025 | 19 | +1 | 60.10M | $508.46M | +2 | −2 |
| Q2 2025 | 16 | -1 | 36.98M | $416.34M | — | −1 |
| Q1 2025 | 14 | 0 | 22.70M | $214.97M | +1 | −1 |
| Q4 2024 | 14 | +1 | 27.38M | $247.73M | +1 | — |
| Q3 2024 | 12 | 0 | 21.00M | $593.78M | +1 | −1 |
| Q2 2024 | 12 | — | 19.79M | $378.42M | — | — |
보유 현황 · Q3 2025
| # | 운용사 | 주식 수 | Δ 주식 수 | 가치 | 비중 | 보유 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (패시브) | 10.97M | +0.4% | $92.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (패시브) | 10.97M | +0.4% | $92.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (패시브) | 10.97M | +0.4% | $92.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (패시브) | 10.97M | +0.4% | $92.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (패시브) | 10.97M | +0.4% | $92.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | BlackRock ✦ (패시브) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Fidelity (FMR) ✦ | 8.75M | +36.3% | $74.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 8.75M | +36.3% | $74.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 8.75M | +36.3% | $74.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 8.75M | +36.3% | $74.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 8.75M | +36.3% | $74.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 8.00M | — | $67.70M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Morgan Stanley ✦ | 7.98M | — | $67.50M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | State Street Global Advisors ✦ (패시브) | 2.97M | +0.1% | $25.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 59 | State Street Global Advisors ✦ (패시브) | 2.97M | +0.1% | $25.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 60 | Geode Capital Management ✦ (패시브) | 2.76M | +3.4% | $23.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 61 | Geode Capital Management ✦ (패시브) | 2.76M | +3.4% | $23.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 62 | D. E. Shaw & Co. ✦ | 2.74M | +30.1% | $23.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 63 | D. E. Shaw & Co. ✦ | 2.74M | +30.1% | $23.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 64 | D. E. Shaw & Co. ✦ | 2.74M | +30.1% | $23.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 65 | D. E. Shaw & Co. ✦ | 2.74M | +30.1% | $23.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 66 | Citadel Advisors ✦ | 2.30M | +291.3% | $19.43M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 67 | Citadel Advisors ✦ | 2.30M | +291.3% | $19.43M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 68 | Goldman Sachs Group ✦ | 881.34K | — | $7.46M | 0.0% | n/c | 1 | SEC ↗ |
| 69 | Goldman Sachs Group ✦ | 881.34K | — | $7.46M | 0.0% | n/c | 1 | SEC ↗ |
| 70 | Two Sigma Investments ✦ | 851.14K | +133.8% | $7.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 71 | Marshall Wace ✦ | 654.75K | +2345.0% | $5.54M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 72 | Marshall Wace ✦ | 654.75K | +2345.0% | $5.54M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 73 | Marshall Wace ✦ | 654.75K | +2345.0% | $5.54M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 74 | Point72 Asset Management ✦ | 601.98K | 신규 | $5.09M | 0.0% | New | 1 | SEC ↗ |
| 75 | Millennium Management ✦ | 456.62K | -27.5% | $3.86M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 76 | Millennium Management ✦ | 456.62K | -27.5% | $3.86M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 77 | Renaissance Technologies ✦ | 310.10K | 신규 | $2.62M | 0.0% | New | 1 | SEC ↗ |
| 78 | GAMCO Investors ✦ | 244.00K | -0.5% | $2.06M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 79 | GAMCO Investors ✦ | 244.00K | -0.5% | $2.06M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 80 | Adage Capital Partners ✦ | 188.52K | -34.7% | $1.59M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 81 | T. Rowe Price ✦ | 115.76K | +9.4% | $980,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 82 | AQR Capital Management ✦ | 18.50K | -10.7% | $156,517 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 83 | AQR Capital Management ✦ | 18.50K | -10.7% | $156,517 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 84 | AQR Capital Management ✦ | 18.50K | -10.7% | $156,517 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 85 | AQR Capital Management ✦ | 18.50K | -10.7% | $156,517 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"해당 운용사 비중" = 해당 운용사의 신고된 13F 주식 가치 대비 포지션 비중 — 확신도 지표. ✦ = 선별 운용사.
신규 매수자
| Point72 Asset Management | $5.09M | 0.0% |
| Renaissance Technologies | $2.62M | 0.0% |
청산됨
| Norges Bank | $2.02M | 이었음 0.0% |
| Wellington Management | $729,986 | 이었음 0.0% |
전체 시장 맥락: 전체 13F 공시 기관 기준 (SEC 구조화 데이터, Q1 2026): 1 보유 기관, 7.50M 주식, $3.77M 신고 기준. 이는 위의 추적 유니버스 수치와 다른 이전 기간으로, 두 수치는 절대 혼용되지 않습니다.
공동 보유 빈도 높음
이 증권의 추적 보유자들이 가장 많이 함께 보유하는 종목 — 기본적 관계가 아닌 공동 보유 건수 기준.
출처: 파싱된 13F 보통주 포지션 기반 보유 현황(추적 유니버스, 변동 비교 세트); 내부자 행은 Form 3/4/5에서; 지분은 Schedule 13D/13G에서 수집; 모든 공시는 SEC EDGAR 원문으로 연결됩니다.
보고 기간: Q3 2025 ·
방법론 ·
API를 통해 조회